Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May;31(5):e16199.
doi: 10.1111/ene.16199. Epub 2024 Feb 26.

Intermediate conduction velocity in two cases of Charcot-Marie-Tooth disease type 1A

Affiliations
Case Reports

Intermediate conduction velocity in two cases of Charcot-Marie-Tooth disease type 1A

Pedro José Tomaselli et al. Eur J Neurol. 2024 May.

Abstract

Background and purpose: Charcot-Marie-Tooth disease type 1A (CMT1A) is the most prevalent hereditary neuropathy worldwide and classically has slow nerve conduction velocity (NCV), in most cases below 38 m/s. Two unrelated patients with motor NCVs in the upper limbs above 38 m/s are reported.

Method: Case report.

Results: Two genetically confirmed CMT1A patients are presented, from two unrelated families (one of British origin and the other of Brazilian origin). Both individuals had upper limb motor NCVs above 38 m/s, with values ranging from 41.9 to 45 m/s in the median nerve and from 42 to 42.3 m/s in the ulnar nerve. They presented with a very mild phenotype, with CMT Neuropathy Score version 2 (CMTNSv2) of 6 and 5, respectively. In contrast, affected family members within both kinships exhibited a classical phenotype with more severe disease manifestation (CMTNSv2 ranging from 12 to 20) and motor NCVs below 30 m/s.

Conclusion: These cases, although very rare, highlight the importance of testing PMP22 duplication in patients with intermediate conduction velocities.

Keywords: PMP22; Charcot−Marie−Tooth disease; electromyography; hereditary sensory and motor neuropathy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Wise CA, Garcia CA, Davis SN, et al. Molecular analyses of unrelated Charcot−Marie−Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am J Hum Genet. 1993;53:853‐863. - PMC - PubMed
    1. García A, Combarros O, Calleja J, Berciano J. Charcot−Marie−Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology. 1998;50(4):1061‐1067. - PubMed
    1. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Nerve conduction studies in Charcot−Marie−Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology. 1993;43(9):1806‐1808. - PubMed
    1. Krampitz DE, Wolfe GI, Fleckenstein JL, Barohn RJ. Charcot−Marie−Tooth disease type 1A presenting as calf hypertrophy and muscle cramps. Neurology. 1998;51:1508‐1509. - PubMed
    1. Saporta ASD, Sottile SL, Miller LJ, Feely SME, Siskind CE, Shy ME. Charcot−Marie−Tooth (CMT) subtypes and genetic testing strategies. Ann Neurol. 2011;69(1):22‐33. - PMC - PubMed

Publication types